University of Montana

ScholarWorks at University of Montana
University of Montana News Releases, 1928,
1956-present

University Relations

3-20-1974

$5,000 from Hoffman-La Rocher to UM for development of blood
test
University of Montana--Missoula. Office of University Relations

Follow this and additional works at: https://scholarworks.umt.edu/newsreleases

Let us know how access to this document benefits you.
Recommended Citation
University of Montana--Missoula. Office of University Relations, "$5,000 from Hoffman-La Rocher to UM
for development of blood test" (1974). University of Montana News Releases, 1928, 1956-present. 23062.
https://scholarworks.umt.edu/newsreleases/23062

This News Article is brought to you for free and open access by the University Relations at ScholarWorks at
University of Montana. It has been accepted for inclusion in University of Montana News Releases, 1928,
1956-present by an authorized administrator of ScholarWorks at University of Montana. For more information,
please contact scholarworks@mso.umt.edu.

t------~ news
Information Services

u iversity

of

m ntana • missoula, montana

59801 • (406) 243-2522
sale/dm
3-20-74
state +- cs +

IMMEDIATELY

$5,000 FR0~1 HOFFMANN-LA ROCHE TO
FOR DEVELOPi.IENT OF BLOOD TEST

UM

MISSOULA---

The University of Montana in Missoula has received a $5,000 grant from Hoffmann-La
Roche Inc., a medical and chemical firm, for a six-month study to determine the feasibility
of converting a skin test for gonorrhea into a simple blood

test for the disease.

Dr. Walter L. Koostra, an assistant professor of microbiology at UM who is director
of the study, will utilize blood samples from a number of local medical sources during
the project, which will continue until Oct. 1 in University laboratories.
Koostra said an advantage

of a gonorrheal blood test compared with the skin test

is that blood taken from a patient can be treated at will,whereas the substance used in
the skin test must undergo rigorous testing before it can be used on individual patients.
"Also, the gonorrheal blood test can be combined with a well known blood test for
syp} ilis from the same blood sample, " Koostra said.
Commenting on the comparative advantages of various test

results, Koostra said:

"While the results of a blood test are almost immediate, the results of a skin test
usually aren't known for about two days, which may represent a considerable delay in the
start of medical treatment.

Also, when a patient sees the results of a skin test he may

decide not to return to the doctor for needed medical treatment."
Koostra said the gonorrheal blood test will have to meet at least two requirements
in order to be valuable medically--it must measure only the presence or absence of
gonorrhea and it must be simple and economical.
The grant to the University is being administered through the University of Montana
Foundation.

Hoffmann-La Roche Inc. has international headquarters in Basel, Switzerland,

N.J.

